Advertisement

nContact gets a nod from the FDA for its next-generation cardiac device with added sensing technology.

nContact logo

nContact said it's received FDA clearance for modifications made to its cardiac ablation device.

The Research Triangle Park, N.C.-based device medical device company won 510(k) clearance from the federal watchdog agency for the next generation of its VisiTrax cardiac ablation device, EPi-Sense. The company says this product includes new sensors, generating electrical feedback to assist electrophysiologists with device positioning during cardiac ablation procedures.

Advertisement
Advertisement